Portfolio

Dr. Pere Gascón selected the most recently published information by ASCO on the advances in the management of prostate cancer and they evaluate their impact on daily clinical practice. Recent information is offered on Epidemiology, Risk Factors, treatment of localized, advanced and metastatic prostate cancer, new treatments and personalized medicine. This extraordinary and y completely updated self-assessment program is offered in a collection of...

Dr. Pere Gascón selected the most recently published information by ASCO on the advances in the management of the Lung CRC and they evaluate their impact on daily clinical practice. Recent information is offered on Genetics and Epigenetics, Tumor markers, management of early, locally advanced and metastatic disease, new molecular targets and new treatments. This extraordinary and recently updated self-assessment program is offered in a collection...

Dr. Leonidas Platanias from Northwestern University, Chicago and the editorin-chief of the series, Dr. Pere Gascón, selected the most recently published information by ASCO on the new findings in translational oncology and they evaluate their impact on daily clinical practice. Recent information is offered on new translational concepts, epigenetics, tumoral development and invasion, mechanisms

Dr. John Kirkwood, one of the most prestigious experts in the area and the editor-in-chief of the series, Dr. Pere Gascón, selected the most recently published information by ASCO on advances in the management of malignant melanoma and they evaluate their impact on daily clinical practice. Recent information is offered on Epidemiology, risk factors, treatment of early, advanced and metastatic disease, prognostic and predictive factors and immunot...